mobile menu
Basic and clinical science SGLT2 therapies
02-Dec-15
Forst, Prof. T.
SGLT2 inhibitors: efficacy (Archive)
18-Sep-14
Ceriello, Prof. A.
SGLT2 inhibitors: new outcome studies (Archive)
16-Sep-14
Seufert, Prof. J.
SGLT2 inhibitors: non-glycaemic endpoints (Archive)
16-Sep-14
Schnell, Prof. O.
Mode of action and clinical rationale of SGLT2 inhibitors (Archive)
15-Sep-14
Fioretto, Prof. P.
Clinical potential of SGLT2 inhibition in the advanced stages of treatment (Archive)
15-Sep-14
Schernthaner, Prof. G.
Clinical potential of SGLT2 inhibition in the early stages of treatment (Archive)
15-Sep-14
Wilding, Prof. J.
Interactive debate session part 1: How do SGLT2 inhibitors fit into individualized management of type 2 diabetes? (Archive)
15-Sep-14
Stumvoll, Prof. M. / Fioretto, Prof. P. / Wilding, Prof. J. / Schernthaner, Prof. G.
Interactive debate session part 2: How do SGLT2 inhibitors fit into individualized management of type 2 diabetes? (Archive)
15-Sep-14
Stumvoll, Prof. M. / Fioretto, Prof. P. / Wilding, Prof. J. / Schernthaner, Prof. G.
Interactive debate session part 3: How do SGLT2 inhibitors fit into individualized management of type 2 diabetes? (Archive)
15-Sep-14
Stumvoll, Prof. M. / Fisher, Dr. W. / Wilding, Prof. J. / Schernthaner, Prof. G.
An innovative treatment target for managing type 2 diabetes: evidence from SGLT-2 inhibitor trials (Archive)
23-Sep-13
Hadjadj, Dr. S.
Clinical experience with dapagliflozin (Archive)
23-Sep-13
Rossing, Dr. P.
From UKPDS to SAVOR: the evolving landscape of CV outcomes studies in type 2 diabetes (Archive)
23-Sep-13
Barnett, Prof. A.
Summary (Archive)
23-Sep-13
Nauck, Prof. M. A.
How could we transform treatment in type 2 diabetes: which approach, when and for whom? (Archive)
23-Sep-13
Nauck, Prof. M. A. / Barnett, Prof. A. / Vilsboll, Dr. T. / Hadjadj, Dr. S. / Rossing, Dr. P. / Mannucci, Dr. E. / Darius, Prof. Dr. H. / Mathieu, Prof. Ch.
A novel way of treating type 2 diabetes: removing excess glucose through SGLT2 inhibition (Archive)
01-Oct-12
Fioretto, Prof. P.
SGLT2 inhibition in clinical practice (Archive)
01-Oct-12
Hadjadj, Dr. S.
Is SGLT2 inhibition safe for my patients? (Archive)
01-Oct-12
Pfeiffer, Prof. A. F. H.
Interactive session & panel discussion (Archive)
01-Oct-12
Pfeiffer, Prof. A. F. H. / Vora, Prof. J. / Khunti, Prof. K. / Fioretto, Prof. P. / Hadjadj, Dr. S. / Mannucci, Dr. E. / Schumm-Draeger, Prof. P.-M. / Baggio, L.
Introducing SAVOR, a prospective cardiovascular outcomes study (Archive)
01-Oct-12
Schumm-Draeger, Prof. P.-M.